216 related articles for article (PubMed ID: 18690304)
1. Tissue necrosis after chemotherapy in osteosarcoma as the important prognostic factor.
Sami SH; Rafati AH; Hodjat P
Saudi Med J; 2008 Aug; 29(8):1124-9. PubMed ID: 18690304
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous necrosis in osteosarcoma.
Springfield DS; Schakel ME; Spanier SS
Clin Orthop Relat Res; 1991 Feb; (263):233-7. PubMed ID: 1993380
[TBL] [Abstract][Full Text] [Related]
3. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients.
Bacci G; Longhi A; Cesari M; Versari M; Bertoni F
Cancer; 2006 Jun; 106(12):2701-6. PubMed ID: 16691623
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma.
Harting MT; Blakely ML; Jaffe N; Cox CS; Hayes-Jordan A; Benjamin RS; Raymond AK; Andrassy RJ; Lally KP
J Pediatr Surg; 2006 Jan; 41(1):194-9. PubMed ID: 16410132
[TBL] [Abstract][Full Text] [Related]
5. Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution.
Bacci G; Mercuri M; Longhi A; Ferrari S; Bertoni F; Versari M; Picci P
Eur J Cancer; 2005 Sep; 41(14):2079-85. PubMed ID: 16115755
[TBL] [Abstract][Full Text] [Related]
6. Telangiectatic osteosarcoma of the extremity: neoadjuvant chemotherapy in 24 cases.
Bacci G; Ferrari S; Ruggieri P; Biagini R; Fabbri N; Campanacci L; Bacchini P; Longhi A; Forni C; Bertoni F
Acta Orthop Scand; 2001 Apr; 72(2):167-72. PubMed ID: 11372948
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).
Juergens H; Kosloff C; Nirenberg A; Mehta BM; Huvos AG; Rosen G
Natl Cancer Inst Monogr; 1981 Apr; (56):221-6. PubMed ID: 6975439
[TBL] [Abstract][Full Text] [Related]
9. Osteosarcoma chemotherapy effect: a prognostic factor.
Raymond AK; Chawla SP; Carrasco CH; Ayala AG; Fanning CV; Grice B; Armen T; Plager C; Papadopoulos NE; Edeiken J
Semin Diagn Pathol; 1987 Aug; 4(3):212-36. PubMed ID: 3313606
[TBL] [Abstract][Full Text] [Related]
10. Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome.
Baldini N; Scotlandi K; Barbanti-Bròdano G; Manara MC; Maurici D; Bacci G; Bertoni F; Picci P; Sottili S; Campanacci M
N Engl J Med; 1995 Nov; 333(21):1380-5. PubMed ID: 7477118
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients.
Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
Ann Surg Oncol; 2008 Mar; 15(3):906-14. PubMed ID: 18163171
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate levels and outcome in osteosarcoma.
Zelcer S; Kellick M; Wexler LH; Shi W; Sankaran M; Lo S; Healey J; Huvos AG; Meyers PA; Gorlick R
Pediatr Blood Cancer; 2005 Jun; 44(7):638-42. PubMed ID: 15704189
[TBL] [Abstract][Full Text] [Related]
13. Post operative infection and increased survival in osteosarcoma patients: are they associated?
Jeys LM; Grimer RJ; Carter SR; Tillman RM; Abudu A
Ann Surg Oncol; 2007 Oct; 14(10):2887-95. PubMed ID: 17653803
[TBL] [Abstract][Full Text] [Related]
14. Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma.
Bernthal NM; Federman N; Eilber FR; Nelson SD; Eckardt JJ; Eilber FC; Tap WD
Cancer; 2012 Dec; 118(23):5888-93. PubMed ID: 22648705
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic factors for 72 patients with osteosarcoma of the extremity treated with neoadjuvant chemotherapy].
Liu J; Guo W; Yang RL; Tang XD; Yang Y
Zhonghua Wai Ke Za Zhi; 2008 Aug; 46(15):1166-70. PubMed ID: 19094683
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases.
Bacci G; Longhi A; Forni C; Fabbri N; Briccoli A; Barbieri E; Mercuri M; Balladelli A; Ferrari S; Picci P
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):505-11. PubMed ID: 17118571
[TBL] [Abstract][Full Text] [Related]
17. The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma.
Wunder JS; Paulian G; Huvos AG; Heller G; Meyers PA; Healey JH
J Bone Joint Surg Am; 1998 Jul; 80(7):1020-33. PubMed ID: 9698007
[TBL] [Abstract][Full Text] [Related]
18. Use of intra-arterial chemotherapy and embolization before limb salvage surgery for osteosarcoma of the lower extremity.
Zhang HJ; Yang JJ; Lu JP; Lai CJ; Sheng J; Li YX; Hao Q; Zhang SM; Gupta S
Cardiovasc Intervent Radiol; 2009 Jul; 32(4):672-8. PubMed ID: 19296158
[TBL] [Abstract][Full Text] [Related]
19. Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7).
Rosen G; Nirenberg A; Caparros B; Juergens H; Kosloff C; Mehta BM; Marcove RC; Huvos AG
Natl Cancer Inst Monogr; 1981 Apr; (56):213-20. PubMed ID: 6946291
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of prognostic factors in osteosarcoma adult patients, a single institution experience].
Adamkova Krakorova D; Vesely K; Zambo I; Tucek S; Tomasek J; Jureckova A; Janicek P; Cerny J; Pazourek L; Ondrusek S; Selingerova I
Klin Onkol; 2012; 25(5):346-58. PubMed ID: 23102196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
